Summary of Significant Accounting Policies (Tables)

12 Months Ended

Jun. 30, 2015

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	Fiscal Year Ended June 30,
Medical Indication	2015		2014		2013
Antibiotic	$	12,306	$	13,572	$	9,167
Cardiovascular	55,166		62,121		25,876
Gallstone	65,262		6,578		6,114
Glaucoma	21,145		11,987		6,410
Gout	6,833		10,822		5,092
Migraine	25,729		14,527		5,418
Muscle Relaxant	8,779		—		—
Obesity	4,004		4,032		4,721
Pain Management	27,461		27,174		21,232
Thyroid Deficiency	153,460		102,248		57,978
Other	26,692		20,710		9,046
Total	$	406,837	$	273,771	$	151,054

Summary of products which accounted for at least 10% of net sales

	June 30, 2015		June 30, 2014		June 30, 2013
Product 1	38	%	37	%	38	%
Product 2	16	%	2	%	4	%
Product 3	12	%	20	%	8	%
Product 4	6	%	8	%	10	%

Summary of customers which accounted for at least 10% of net sales

	June 30, 2015		June 30, 2014		June 30, 2013
Customer A	30	%	19	%	12	%
Customer B	11	%	8	%	9	%
Customer C	7	%	9	%	10	%
Customer D	—	%	13	%	17	%